Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study.

M. Ripamonti, S. Canevari, G. Buraggi, M. Gadina, A. Turrin, M. Gasparini, G. Scassellati, M. I. Colnaghi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

131I-labelled anti-CEA monoclonal antibody was tested in an animal model to evaluate: influence of antibody type (whole versus F(ab')2 fragments), administration route (i.v. versus i.p.), dose of tracer (100 microCi versus 1000 microCi), growth site (s.c. versus i.p.) and size of tumor. Athymic mice bearing CEA-producing human colon carcinoma (HT-29) or human melanoma as an irrelevant tumor (MeWo) received tracer and immunoscintigraphy and the localization ratios (LR) were compared. In HT-29 bearing animals F(ab')2 fragments localized better than the whole antibody. The LR were higher after i.p. administration of the tracer, independently of the tumor characteristics or the injected dose. The highest values were achieved when the radioactivity remaining in the whole body was below 2% of the injected dose. The images were negative when the i.p. injected dose was low or tumor growth was i.p. but positive in the other conditions (i.v. administration, high tracer dose, s.c. tumor growth). In the animals bearing melanoma, images scored positive or negative when the tumor weight was respectively above or below 400 mg, but the LR were always low.

Original languageEnglish
Pages (from-to)249-258
Number of pages10
JournalInternational Journal of Biological Markers
Volume3
Issue number4
Publication statusPublished - Oct 1988

Fingerprint

Tumors
Anti-Idiotypic Antibodies
Bearings (structural)
Monoclonal Antibodies
Antibodies
Neoplasms
Animals
Melanoma
Growth
Tumor Burden
Nude Mice
Radioactivity
Colon
Animal Models
Carcinoma

ASJC Scopus subject areas

  • Biochemistry
  • Immunology

Cite this

Ripamonti, M., Canevari, S., Buraggi, G., Gadina, M., Turrin, A., Gasparini, M., ... Colnaghi, M. I. (1988). Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study. International Journal of Biological Markers, 3(4), 249-258.

Monoclonal anti-CEA antibody : factors affecting localization in a preclinical study. / Ripamonti, M.; Canevari, S.; Buraggi, G.; Gadina, M.; Turrin, A.; Gasparini, M.; Scassellati, G.; Colnaghi, M. I.

In: International Journal of Biological Markers, Vol. 3, No. 4, 10.1988, p. 249-258.

Research output: Contribution to journalArticle

Ripamonti, M, Canevari, S, Buraggi, G, Gadina, M, Turrin, A, Gasparini, M, Scassellati, G & Colnaghi, MI 1988, 'Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study.', International Journal of Biological Markers, vol. 3, no. 4, pp. 249-258.
Ripamonti, M. ; Canevari, S. ; Buraggi, G. ; Gadina, M. ; Turrin, A. ; Gasparini, M. ; Scassellati, G. ; Colnaghi, M. I. / Monoclonal anti-CEA antibody : factors affecting localization in a preclinical study. In: International Journal of Biological Markers. 1988 ; Vol. 3, No. 4. pp. 249-258.
@article{697bf1e6aa524ec59c1232bcfa0fd025,
title = "Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study.",
abstract = "131I-labelled anti-CEA monoclonal antibody was tested in an animal model to evaluate: influence of antibody type (whole versus F(ab')2 fragments), administration route (i.v. versus i.p.), dose of tracer (100 microCi versus 1000 microCi), growth site (s.c. versus i.p.) and size of tumor. Athymic mice bearing CEA-producing human colon carcinoma (HT-29) or human melanoma as an irrelevant tumor (MeWo) received tracer and immunoscintigraphy and the localization ratios (LR) were compared. In HT-29 bearing animals F(ab')2 fragments localized better than the whole antibody. The LR were higher after i.p. administration of the tracer, independently of the tumor characteristics or the injected dose. The highest values were achieved when the radioactivity remaining in the whole body was below 2{\%} of the injected dose. The images were negative when the i.p. injected dose was low or tumor growth was i.p. but positive in the other conditions (i.v. administration, high tracer dose, s.c. tumor growth). In the animals bearing melanoma, images scored positive or negative when the tumor weight was respectively above or below 400 mg, but the LR were always low.",
author = "M. Ripamonti and S. Canevari and G. Buraggi and M. Gadina and A. Turrin and M. Gasparini and G. Scassellati and Colnaghi, {M. I.}",
year = "1988",
month = "10",
language = "English",
volume = "3",
pages = "249--258",
journal = "International Journal of Biological Markers",
issn = "0393-6155",
publisher = "Wichtig Publishing Srl",
number = "4",

}

TY - JOUR

T1 - Monoclonal anti-CEA antibody

T2 - factors affecting localization in a preclinical study.

AU - Ripamonti, M.

AU - Canevari, S.

AU - Buraggi, G.

AU - Gadina, M.

AU - Turrin, A.

AU - Gasparini, M.

AU - Scassellati, G.

AU - Colnaghi, M. I.

PY - 1988/10

Y1 - 1988/10

N2 - 131I-labelled anti-CEA monoclonal antibody was tested in an animal model to evaluate: influence of antibody type (whole versus F(ab')2 fragments), administration route (i.v. versus i.p.), dose of tracer (100 microCi versus 1000 microCi), growth site (s.c. versus i.p.) and size of tumor. Athymic mice bearing CEA-producing human colon carcinoma (HT-29) or human melanoma as an irrelevant tumor (MeWo) received tracer and immunoscintigraphy and the localization ratios (LR) were compared. In HT-29 bearing animals F(ab')2 fragments localized better than the whole antibody. The LR were higher after i.p. administration of the tracer, independently of the tumor characteristics or the injected dose. The highest values were achieved when the radioactivity remaining in the whole body was below 2% of the injected dose. The images were negative when the i.p. injected dose was low or tumor growth was i.p. but positive in the other conditions (i.v. administration, high tracer dose, s.c. tumor growth). In the animals bearing melanoma, images scored positive or negative when the tumor weight was respectively above or below 400 mg, but the LR were always low.

AB - 131I-labelled anti-CEA monoclonal antibody was tested in an animal model to evaluate: influence of antibody type (whole versus F(ab')2 fragments), administration route (i.v. versus i.p.), dose of tracer (100 microCi versus 1000 microCi), growth site (s.c. versus i.p.) and size of tumor. Athymic mice bearing CEA-producing human colon carcinoma (HT-29) or human melanoma as an irrelevant tumor (MeWo) received tracer and immunoscintigraphy and the localization ratios (LR) were compared. In HT-29 bearing animals F(ab')2 fragments localized better than the whole antibody. The LR were higher after i.p. administration of the tracer, independently of the tumor characteristics or the injected dose. The highest values were achieved when the radioactivity remaining in the whole body was below 2% of the injected dose. The images were negative when the i.p. injected dose was low or tumor growth was i.p. but positive in the other conditions (i.v. administration, high tracer dose, s.c. tumor growth). In the animals bearing melanoma, images scored positive or negative when the tumor weight was respectively above or below 400 mg, but the LR were always low.

UR - http://www.scopus.com/inward/record.url?scp=0024101585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024101585&partnerID=8YFLogxK

M3 - Article

C2 - 3235853

AN - SCOPUS:0024101585

VL - 3

SP - 249

EP - 258

JO - International Journal of Biological Markers

JF - International Journal of Biological Markers

SN - 0393-6155

IS - 4

ER -